Figure 3.

Change from baseline in office systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure (PP) with sacubitril/valsartan 200 mg vs olmesartan 20 mg at week 8. LSM indicates least square mean

Change from baseline in office systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure (PP) with sacubitril/valsartan 200 mg vs olmesartan 20 mg at week 8. LSM indicates least square mean